Temara Hajjat, MD

Attending Physician, Division of Gastroenterology, Hepatology, and Nutrition
Assistant Professor, UC Department of Pediatrics

temara.hajjat@cchmc.org
Board Certified

Burnet Campus

Make An Appointment

New PatientsSchedule OnlineSchedule Online

Existing PatientsMyChart SchedulingMyChart Scheduling

Call Us to ScheduleAppointments1-513-636-3200Appointments

About

MD: Jordan University of Science and Technology, Irbid, Jordan.

Residency: Pediatrics, King Abdullah University Hospital, Irbid, Jordan.

Residency: Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA.

Fellowship: Pediatric Gastroenterology, Connecticut Children's Medical Center, Hartford, CT.

Services and Specialties

Gastroenterology

Research Areas

Gastroenterology Hepatology and Nutrition

Additional Languages

Arabic

Location

Burnet Campus

3333 Burnet Ave
Cincinnati, OH 45229

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

50 Years Ago in TheJournalofPediatrics: Celiac Disease: Do We Know More Now?. Hajjat, TM; Balistreri, W. The Journal of Pediatrics. 2022; 250:66.

Vedolizumab Experience in Children and Adolescents With Inflammatory Bowel Disease: A Multicenter Observational Study. Hajjat, TM; Mosha, M; Whaley, KG; Rosen, MJ; Suppa, C; Markowitz, J; Dufour, L; Sauer, C; Shukla-Udawatta, M; Boyle, B; et al. Crohn's && Colitis 360. 2021; 3:otab039.

Serologic Evaluation of Celiac Disease for Patients Younger Than 2 Years of Age. Mallon, D; Hajjat, TM. The Journal of Pediatrics. 2020; 224:16-17.

Mo1796 – Vedolizumab Experience in Children and Adolescents with Inflammatory Bowel Disease: A Multicenter Observational Study (VOLCANO). Hajjat, T; Mosha, MH; Suppa, C; Markowitz, J; Whaley, KG; Rosen, MJ; Shukla-Udawatta, M; Boyle, BM; Hunter, G; Perez, ME; et al. Gastroenterology. 2019; 156:s-840-s-841.

882 – Normalization of Fecal Calprotectin Requires Higher Trough Infliximab Levels in Children with Inflammatory Bowel Disease. Hajjat, T; Mosha, MH; Bonkowski, E; Denson, LA; Hyams, JS. Gastroenterology. 2019; 156:s-200.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6

Overall Patient Rating